NCT05276180 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Strid EN, Wahlin C, Ros A, Kvarnstrom S
Health care workers' experiences of workplace incidents that posed a risk of patient and worker injury: a critical incident technique analysis. BMC Health Serv Res. 2021 May 27;21(1):511. doi: 10.1186/s12913-021-06517-x.
Wahlin C, Stigmar K, Nilsing Strid E
A systematic review of work interventions to promote safe patient handling and movement in the healthcare sector. Int J Occup Saf Ergon. 2022 Dec;28(4):2520-2532. doi: 10.1080/10803548.2021.2007660. Epub 2021 Dec 19.

Evaluation of Implementation and Effectiveness of a Multifactorial Intervention Strategy for Safe Patient Handling and Movement in the Healthcare Sector - A Cluster Randomized Controlled Trial

Details for clinical trial NCT05276180

Clinical trial NCT05276180 - References